search
Back to results

ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy. (ERAS-Gyneco)

Primary Purpose

Uterine Neoplasms

Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
ERAS protocol
Sponsored by
Ospedale Regina Montis Regalis
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Uterine Neoplasms focused on measuring Hysterectomy, Uterine Cervical Neoplasms, Endometrial Neoplasms, Quality Improvement, Perioperative Care, Recovery of Function

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • All the hospital wards within the Piemonte Region performing hysterectomy.
  • All the patients receiving an elective hysterectomy for benign or malignant tumors of the uterus.

Exclusion Criteria:

  • Hospital wards performing less than 20 expected cases per year
  • Emergency hysterectomy
  • Hysterectomy for pelvic floor disorders
  • High severity cases not allowing ERAS protocol implementation (i.e. American Society of Anesthesiologists score: ASA V).

Sites / Locations

  • Ospedale Regina Montis RegalisRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Usual care

ERAS protocol

Arm Description

Perioperative care for hysterectomy of benign or malignant tumors of the uterus is managed according to current hospital clinical practice.

Perioperative care for hysterectomy of benign or malignant tumors of the uterus is managed according to ERAS protocol.

Outcomes

Primary Outcome Measures

Length of stay
Mean length of stay calculated as difference between date of discharge and date of admission of the hospitalization for surgery, excluding length of stay >12 days (98th percentile of the expected distribution).

Secondary Outcome Measures

Length of stay >12 days
Rate of patients with a length of stay >12 days
Recovery after surgery
Score of quality of recovery at 24 hours after surgery, assessed with the questionnaire Quality of Recovery (QoR-15), a 15-items instrument, with responses recorded on a 11-point Likert-type scale form 0 (worst scenario) to 10 (best scenario) and an overall score ranging from 0 (poor recovery) to 150 (excellent recovery). A visual analogue scale (VAS), ranging from 0 (worst imaginable health state) to 10 (worst imaginable health state) is also supplied as summary evaluation.
Complications
Rate of surgical and medical complication after surgery For surgical complications: Comprehensive Complication Index
Transfer to intensive care unit
Rate of transfers to intensive care unit after surgery
Emergency visits after discharge
Rate of emergency visit in the first month after discharge
Hospital admissions after discharge
Rate of new admissions in the first month after discharge
Reintervention
Rate of reintervention in the first month after surgery, excluding planned interventions
Patients' satisfaction
Score of patients' satisfaction measured 2 weeks after discharge, assessed with the questionnaire Surgical Satisfaction Questionnaire (SSQ8) supplied by telephone. SSQ8 is a 8-items instrument, with responses recorded on a 5-point Likert-type scale from 0 (worst scenario) to 4 (best scenario) and an overall score ranging from 0 (very unsatisfied) to 32 (very satisfied).
Healthcare costs
Mean healthcare costs from pre admission visit to 30 days after discharge

Full Information

First Posted
August 19, 2019
Last Updated
June 1, 2021
Sponsor
Ospedale Regina Montis Regalis
Collaborators
Martini Hospital, Turin, Italy, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Ministry of Health, Italy, Regione Piemonte
search

1. Study Identification

Unique Protocol Identification Number
NCT04063072
Brief Title
ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.
Acronym
ERAS-Gyneco
Official Title
ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy of Benign or Malignant Tumors of the Uterus. A Stepped-wedge Cluster Randomized Clinical Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Unknown status
Study Start Date
September 1, 2019 (Actual)
Primary Completion Date
July 31, 2021 (Anticipated)
Study Completion Date
October 31, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ospedale Regina Montis Regalis
Collaborators
Martini Hospital, Turin, Italy, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Ministry of Health, Italy, Regione Piemonte

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study assesses the impact on quality of care of implementing the ERAS (Enhanced Recovery After Surgery) protocol for hysterectomy of benign or malignant tumors of the uterus in the network of public hospitals in the Regione Piemonte (North-West Italy). Every hospital is a cluster entering the study treating patients according to its current clinical practice. On the basis of a randomized order, each hospital switches from current clinical practice to the adoption of the ERAS protocol.
Detailed Description
ERAS (Enhanced Recovery After Surgery) protocol is a multimodal perioperative care pathways designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery. Even if efficacy and safety of ERAS protocol in gynaecological surgery is well-established in the literature, its implementation is limited to few selected centres in Piemonte. The aim of the study is to extend the implementation of the ERAS protocol to whole regional network of hospitals. Specific objectives are to estimate its impact on different dimensions of quality of care, including length of stay, complications and patient satisfaction, and to identify possible barriers or facilitating factors.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Uterine Neoplasms
Keywords
Hysterectomy, Uterine Cervical Neoplasms, Endometrial Neoplasms, Quality Improvement, Perioperative Care, Recovery of Function

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
A stepped-wedge cluster randomized clinical trial. Each center starts as control group (usual care) and switch to experimental group (ERAS protocol implementation) according to a randomized order.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1800 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Usual care
Arm Type
No Intervention
Arm Description
Perioperative care for hysterectomy of benign or malignant tumors of the uterus is managed according to current hospital clinical practice.
Arm Title
ERAS protocol
Arm Type
Experimental
Arm Description
Perioperative care for hysterectomy of benign or malignant tumors of the uterus is managed according to ERAS protocol.
Intervention Type
Procedure
Intervention Name(s)
ERAS protocol
Other Intervention Name(s)
ERAS (Enhanced Recovery After Surgery) protocol
Intervention Description
In gynecological surgery, the ERAS protocol involves an accurate interview with the patient in the preoperative phase aimed at smoking and alcohol cessation, the reduction of preoperative fasting, the omission of intestinal preparation, the prophylaxis of thromboembolism, a correct antibiotic prophylaxis, the prevention of intraoperative hypothermia, prevention of volume overload, prevention of postoperative nausea and vomiting, very limited use of the nasogastric tube, early removal of the urinary catheter, multimodal analgesia to minimize opiate consumption, early postoperative mobilization and early post-operative feeding, to promote rapid recovery of gastro-intestinal functions.
Primary Outcome Measure Information:
Title
Length of stay
Description
Mean length of stay calculated as difference between date of discharge and date of admission of the hospitalization for surgery, excluding length of stay >12 days (98th percentile of the expected distribution).
Time Frame
12 days after admission
Secondary Outcome Measure Information:
Title
Length of stay >12 days
Description
Rate of patients with a length of stay >12 days
Time Frame
30 days after admission
Title
Recovery after surgery
Description
Score of quality of recovery at 24 hours after surgery, assessed with the questionnaire Quality of Recovery (QoR-15), a 15-items instrument, with responses recorded on a 11-point Likert-type scale form 0 (worst scenario) to 10 (best scenario) and an overall score ranging from 0 (poor recovery) to 150 (excellent recovery). A visual analogue scale (VAS), ranging from 0 (worst imaginable health state) to 10 (worst imaginable health state) is also supplied as summary evaluation.
Time Frame
24 hours after surgery
Title
Complications
Description
Rate of surgical and medical complication after surgery For surgical complications: Comprehensive Complication Index
Time Frame
30 days after discharge
Title
Transfer to intensive care unit
Description
Rate of transfers to intensive care unit after surgery
Time Frame
30 days after surgery
Title
Emergency visits after discharge
Description
Rate of emergency visit in the first month after discharge
Time Frame
30 days after discharge
Title
Hospital admissions after discharge
Description
Rate of new admissions in the first month after discharge
Time Frame
30 days after discharge
Title
Reintervention
Description
Rate of reintervention in the first month after surgery, excluding planned interventions
Time Frame
30 days after surgery
Title
Patients' satisfaction
Description
Score of patients' satisfaction measured 2 weeks after discharge, assessed with the questionnaire Surgical Satisfaction Questionnaire (SSQ8) supplied by telephone. SSQ8 is a 8-items instrument, with responses recorded on a 5-point Likert-type scale from 0 (worst scenario) to 4 (best scenario) and an overall score ranging from 0 (very unsatisfied) to 32 (very satisfied).
Time Frame
15 days after discharge
Title
Healthcare costs
Description
Mean healthcare costs from pre admission visit to 30 days after discharge
Time Frame
30 days after discharge

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Gynecological surgery
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All the hospital wards within the Piemonte Region performing hysterectomy. All the patients receiving an elective hysterectomy for benign or malignant tumors of the uterus. Exclusion Criteria: Hospital wards performing less than 20 expected cases per year Emergency hysterectomy Hysterectomy for pelvic floor disorders High severity cases not allowing ERAS protocol implementation (i.e. American Society of Anesthesiologists score: ASA V).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Andrea Puppo, MD
Phone
0039 0174677
Ext
470
Email
andrea.puppo@aslcn1.it
First Name & Middle Initial & Last Name or Official Title & Degree
Marco Camanni, MD
Phone
0039 011 7095
Ext
2531
Email
marco.camanni@aslcittaditorino.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Giovannino Ciccone, MD
Organizational Affiliation
Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino
Official's Role
Study Chair
Facility Information:
Facility Name
Ospedale Regina Montis Regalis
City
Mondovì
Country
Italy
Individual Site Status
Recruiting

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
30877144
Citation
Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena G, Scott M, Gillis C, Elias K, Wijk L, Huang J, Nygren J, Ljungqvist O, Ramirez PT, Dowdy SC. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer. 2019 May;29(4):651-668. doi: 10.1136/ijgc-2019-000356. Epub 2019 Mar 15.
Results Reference
background
PubMed Identifier
35622826
Citation
Piovano E, Pagano E, Del Piano E, Rinaldi F, Palazzo V, Coata P, Bongiovanni D, Rolfo M, Ceretto Giannone L, Veliaj D, Camanni M, Puppo A, Ciccone G; ERAS-Gyneco Piemonte group. Implementation of the ERAS (Enhanced Recovery After Surgery) protocol for hysterectomy in the Piedmont Region with an audit&feedback approach: Study protocol for a stepped wedge cluster randomized controlled trial. A study of the EASY-NET project. PLoS One. 2022 May 27;17(5):e0268655. doi: 10.1371/journal.pone.0268655. eCollection 2022.
Results Reference
derived
PubMed Identifier
35289396
Citation
Chau JPC, Liu X, Lo SHS, Chien WT, Hui SK, Choi KC, Zhao J. Perioperative enhanced recovery programmes for women with gynaecological cancers. Cochrane Database Syst Rev. 2022 Mar 15;3(3):CD008239. doi: 10.1002/14651858.CD008239.pub5.
Results Reference
derived

Learn more about this trial

ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.

We'll reach out to this number within 24 hrs